Trial
NCT02319616
Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
—
Condition
Toxic Epidermal Necrolysis
Intervention
Clobetasol 0.05% ointment
Why stopped
Lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-09